HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

5.620

+0.0400.72%

Volume:5.84M

Turnover:32.89M

Market Cap:2.20B

PE:-8.75

High:5.845

Open:5.630

Low:5.450

Close:5.580

52wk High:77.000

52wk Low:4.940

Shares:391.00M

HK Float Shares:386.00M

Volume Ratio:0.76

T/O Rate:1.51%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.642

ROE:-125.57%

ROA:-44.55%

PB:7.05

PE(LYR):-8.75

PS:-164.35

Loading ...

Overview Company News Filings

Movement Alert｜PegBio-B Falls 8.3% in Regular Trading, Continued Volatility After H-Share Full Circulation Completion

PegBio’s Visepegenatide Injection Clears Preliminary Hurdle for 2026 China NRDL Inclusion

Bulletin Express

PEGBIO's Key Drug Vipenatide Injection Clears Initial Review for 2026 National Reimbursement List

Movement Alert｜PegBio Rises 17.94% in Regular Trading, Stock Rebounds from Historic Low After H-Share Full Circulation Selloff

PegBio Completes H-Share Full Circulation

MT Newswires Live

Movement Alert｜PegBio Pharmaceutical-B Falls 8.19% in Regular Trading, H-Share Full Circulation Completed with Over 100 Million Shares Newly Listed

PEGBIO CO-B Completes Full H-Share Conversion for Trading

PegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%

Bulletin Express

Pegbio Appoints Yik Lam Liao as Independent Director, Names Her Audit Chair

Movement Alert｜Pegbio Biopharmaceuticals-B Falls 8.23% in Regular Trading, Litigation Risk and Sector Weakness Intensify Selling Pressure

PegBio Receives HK$61 Million in Royalty Payment Over Drug Licensing Deal

MT Newswires Live

Movement Alert｜PegBio Rises 8.37% in Regular Trading, Boosted by HKD 61 Million Commercialization Milestone Payment from Tengrui Pharma

PegBio Co-B Shares Surge Over 6% Following Receipt of HKD 61 Million Initial Royalty Payment for Commercialization of Drug Candidate

PEGBIO CO-B Receives First Commercialization Milestone Payment of HK$61 Million for Weipenataide from Tengrui Pharmaceutical

PegBio receives first HK$ 61 million royalty payment from Tenry Pharma under Visepegenatide deal

Movement Alert｜PegBio Rises 8.52% in Regular Trading, Multiple Positive Catalysts Drive Continued Rebound

PegBio Reports Stable Share Capital in May 2026 and Affirms Public Float Compliance

Bulletin Express

PEGBIO CO-B Shares Surge Over 13% in Session as CR059 Accepted for EASD 2026 and Oral Presentation

PEGBIO CO-B Shares Surge Over 13% as CR059 Research Accepted for Presentation at EASD 2026

Movement Alert｜PegBio Pharma-B Rises 10.55% in Regular Trading, CR059 EASD Oral Presentation Selection and Buyback Plan Boost Sentiment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/02565/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"PEGBIO CO-B","latestPrice":5.62,"timestamp":1789027724005,"preClose":5.58,"halted":0,"volume":5840950,"delay":0,"changeRate":0.007168458781362013,"floatShares":386000000,"shares":391000000,"eps":-0.6423459665466865,"marketStatus":"Not Yet Opened","change":0.04,"latestTime":"09-10 16:08:44","open":5.63,"high":5.845,"low":5.45,"amount":32892209,"amplitude":0.070789,"askPrice":5.62,"askSize":13450,"bidPrice":5.615,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-0.9969115968663986,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":5.58,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.755024,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":386000000,"roa":"-44.55%","roe":"-125.57%","lyrEps":-0.642346,"volumeRatio":0.755024,"shares":391000000,"dividePrice":0,"high":5.845,"amplitude":0.070789,"preClose":5.58,"low":5.45,"week52Low":4.94,"pbRate":"7.05","psRate":"-164.35","week52High":77,"institutionHeld":0,"latestPrice":5.62,"committee":-0.147122,"eps":-0.6423459665466865,"divideRate":0,"volume":5840950,"delay":0,"ttmEps":-0.9969115968663986,"open":5.63,"prevYearClose":69,"prevWeekClose":5.735,"prevMonthClose":5.495,"prevQuarterClose":5.33,"fiveDayClose":5.7,"twentyDayClose":6.455,"sixtyDayClose":6.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-09-09","current":-5.630984,"percent":0.993528,"low":-87.782868,"twenty":-72.567571,"median":-50.277222,"eighty":-11.249462,"high":-5.557418,"avg":-42.712482,"sd":28.499314,"marketCap":2182290748},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-29","current":-13.590249,"twenty":-73.716985,"median":-61.274827,"eighty":-19.064042,"marketCap":3375119921},{"date":"2026-06-05","current":-12.579887,"twenty":-73.438012,"median":-61.206433,"eighty":-18.597951,"marketCap":3128732256},{"date":"2026-06-12","current":-11.565594,"twenty":-73.352041,"median":-60.919795,"eighty":-17.056006,"marketCap":2874522760},{"date":"2026-06-18","current":-9.622776,"twenty":-73.31105,"median":-60.791238,"eighty":-14.753422,"marketCap":2397391091},{"date":"2026-06-26","current":-7.824338,"twenty":-73.278872,"median":-60.512398,"eighty":-13.899973,"marketCap":1939813998},{"date":"2026-07-03","current":-8.984958,"twenty":-73.271235,"median":-60.431019,"eighty":-13.561687,"marketCap":2229221732},{"date":"2026-07-10","current":-11.252888,"twenty":-73.25947,"median":-60.210807,"eighty":-13.050401,"marketCap":2788482623},{"date":"2026-07-17","current":-10.458113,"twenty":-73.235067,"median":-60.159469,"eighty":-12.830773,"marketCap":2600758687},{"date":"2026-07-24","current":-10.046967,"twenty":-73.215248,"median":-60.107782,"eighty":-12.739192,"marketCap":2499074889},{"date":"2026-07-31","current":-8.411523,"twenty":-73.183292,"median":-59.862622,"eighty":-12.522041,"marketCap":2096250611},{"date":"2026-08-07","current":-10.298244,"twenty":-73.061453,"median":-59.675079,"eighty":-12.306772,"marketCap":2571426822},{"date":"2026-08-14","current":-9.745542,"twenty":-72.966779,"median":-59.367669,"eighty":-11.991332,"marketCap":2436500244},{"date":"2026-08-21","current":-9.169953,"twenty":-72.846173,"median":-58.454271,"eighty":-11.546541,"marketCap":2297662750},{"date":"2026-08-28","current":-5.766342,"twenty":-72.790068,"median":-56.898206,"eighty":-11.368021,"marketCap":2225310817},{"date":"2026-09-04","current":-5.809614,"twenty":-72.647581,"median":-53.43223,"eighty":-11.296065,"marketCap":2242909936},{"date":"2026-09-09","current":-5.643565,"twenty":-72.567571,"median":-50.277222,"eighty":-11.249462,"marketCap":2182290748}],"updateTime":1789036849243},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1132087722","title":"Movement Alert｜PegBio-B Falls 8.3% in Regular Trading, Continued Volatility After H-Share Full Circulation Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=1132087722","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132087722?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:47","pubTimestamp":1782787621,"startTime":"0","endTime":"0","summary":"On June 30, PegBio-B (02565.HK) declined 8.3% in regular trading, trading at HK$5.31/share, with turnover of approximately HK$26.38 million.The decline is attributed to ongoing selling pressure...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104589736","title":"PegBio’s Visepegenatide Injection Clears Preliminary Hurdle for 2026 China NRDL Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1104589736","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104589736?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:04","pubTimestamp":1782731082,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PegBio) announced that its core product Visepegenatide injection (trade name: Paidakang®) has been placed on the National Healthcare Security Administration’s list of drugs that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105233104","title":"PEGBIO's Key Drug Vipenatide Injection Clears Initial Review for 2026 National Reimbursement List","url":"https://stock-news.laohu8.com/highlight/detail?id=1105233104","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105233104?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:30","pubTimestamp":1782729038,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) has announced that its core product, Vipenatide Injection (brand name: Paidakang®), has been included in the preliminary formal review list for the 2026 National...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK4581","XBI","161726","BK4588","399441","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110775924","title":"Movement Alert｜PegBio Rises 17.94% in Regular Trading, Stock Rebounds from Historic Low After H-Share Full Circulation Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1110775924","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110775924?lang=en_us&edition=fundamental","pubTime":"2026-06-29 11:08","pubTimestamp":1782702519,"startTime":"0","endTime":"0","summary":"On June 29, PegBio rose 17.94% in regular trading, trading at HK$5.86/share, with turnover of HK$97.03 million.On the news front, the company completed its H-share full circulation on June 25,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646602339","title":"PegBio Completes H-Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2646602339","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646602339?lang=en_us&edition=fundamental","pubTime":"2026-06-26 13:54","pubTimestamp":1782453247,"startTime":"0","endTime":"0","summary":"PegBio (HKG:2565) completed its planned H-share full circulation in Hong Kong, according to a Friday bourse filing.The biopharmaceutical company converted and listed about 101.7 million previously unlisted shares into H-shares under the full-circulation scheme.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158003214","title":"Movement Alert｜PegBio Pharmaceutical-B Falls 8.19% in Regular Trading, H-Share Full Circulation Completed with Over 100 Million Shares Newly Listed","url":"https://stock-news.laohu8.com/highlight/detail?id=1158003214","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158003214?lang=en_us&edition=fundamental","pubTime":"2026-06-26 13:41","pubTimestamp":1782452479,"startTime":"0","endTime":"0","summary":"On June 26, PegBio Pharmaceutical-B declined 8.19% in regular trading, trading at HK$5.25 per share, with turnover of approximately HK$41.46 million.On the news front, the company announced the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114452816","title":"PEGBIO CO-B Completes Full H-Share Conversion for Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1114452816","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114452816?lang=en_us&edition=fundamental","pubTime":"2026-06-26 13:40","pubTimestamp":1782452439,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (02565) has announced the successful completion of the conversion of 102 million non-traded shares into H-shares.The conversion was finalized on June 25, 2026.These newly converted H-shares commenced trading on the Hong Kong Stock Exchange starting at 9:00 AM on June 26, 2026.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","161726","BK4585","BK4588","BK1161","BK4581","399441","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184250474","title":"PegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184250474","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184250474?lang=en_us&edition=fundamental","pubTime":"2026-06-26 12:23","pubTimestamp":1782447837,"startTime":"0","endTime":"0","summary":"On 26 June 2026, PegBio Co., Ltd. (abbreviated as “PegBio”) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, confirming the conversion of 101.70 million unlisted shares into H...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645892645","title":"Pegbio Appoints Yik Lam Liao as Independent Director, Names Her Audit Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2645892645","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645892645?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:55","pubTimestamp":1782298540,"startTime":"0","endTime":"0","summary":"PegBio appoints Yik Lam Liao as independent director, names her audit chairPegBio appointed Yik Lam Liao as an independent non-executive director, effective June 24, 2026, following shareholder voting","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL4gfpMx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183413158","title":"Movement Alert｜Pegbio Biopharmaceuticals-B Falls 8.23% in Regular Trading, Litigation Risk and Sector Weakness Intensify Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1183413158","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183413158?lang=en_us&edition=fundamental","pubTime":"2026-06-16 11:47","pubTimestamp":1781581627,"startTime":"0","endTime":"0","summary":"On June 16, Pegbio Biopharmaceuticals-B declined 8.23% in regular trading, trading at HK$6.48/share, with turnover of HK$35.48 million. The stock hit a fresh 52-week low amid persistent market...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641510319","title":"PegBio Receives HK$61 Million in Royalty Payment Over Drug Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2641510319","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641510319?lang=en_us&edition=fundamental","pubTime":"2026-06-08 12:31","pubTimestamp":1780893062,"startTime":"0","endTime":"0","summary":"PegBio  received the first royalty payment of HK$61 million from Shanghai Tenry Pharmaceutical over a licensing deal covering visepegenatide in China, according to a Friday filing with the Hong Kong bourse.The medicine, sold under the Paidakang brand name, is intended to treat type 2 diabetes.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141451062","title":"Movement Alert｜PegBio Rises 8.37% in Regular Trading, Boosted by HKD 61 Million Commercialization Milestone Payment from Tengrui Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1141451062","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141451062?lang=en_us&edition=fundamental","pubTime":"2026-06-08 10:22","pubTimestamp":1780885359,"startTime":"0","endTime":"0","summary":"On June 8, PegBio (Peg Bio Pharmaceuticals-B) rose 8.37% in regular trading, trading at HKD 8.4 per share, with trading volume of approximately HKD 93.36 million.On the news front, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124962385","title":"PegBio Co-B Shares Surge Over 6% Following Receipt of HKD 61 Million Initial Royalty Payment for Commercialization of Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1124962385","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124962385?lang=en_us&edition=fundamental","pubTime":"2026-06-08 09:38","pubTimestamp":1780882703,"startTime":"0","endTime":"0","summary":"PegBio Co-B (ASX: 02565) shares have surged more than 6%. At the time of writing, the stock is up 5.38% to HKD 8.43, with a turnover of HKD 31.46 million.The significant price movement follows a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1161","399441","02565","BK1191","01477","161726","BK4581","XBI","VXUS","BK1574","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182527756","title":"PEGBIO CO-B Receives First Commercialization Milestone Payment of HK$61 Million for Weipenataide from Tengrui Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1182527756","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182527756?lang=en_us&edition=fundamental","pubTime":"2026-06-05 18:12","pubTimestamp":1780654348,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) has announced that it has received the initial milestone payment of HK$61 million from Shanghai Tengrui Pharmaceutical Co., Ltd. This payment pertains to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1191","BK4588","BK1574","XBI","399441","161726","01477","BK4581","BK4585","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641111006","title":"PegBio receives first HK$ 61 million royalty payment from Tenry Pharma under Visepegenatide deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2641111006","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641111006?lang=en_us&edition=fundamental","pubTime":"2026-06-05 18:06","pubTimestamp":1780653971,"startTime":"0","endTime":"0","summary":"PegBio received its first royalty payment of HK$61 million from Tenry Pharmaceutical under their Visepegenatide  commercialization collaboration.The payment signals the collaboration has moved into substantial execution in mainland China.Paidakang is a once-weekly GLP-1 receptor agonist marketed for type 2 diabetes in China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pegbio Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL11xp6y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152329611","title":"Movement Alert｜PegBio Rises 8.52% in Regular Trading, Multiple Positive Catalysts Drive Continued Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1152329611","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152329611?lang=en_us&edition=fundamental","pubTime":"2026-06-04 13:42","pubTimestamp":1780551768,"startTime":"0","endTime":"0","summary":"On June 4, PegBio (02565.HK) rose 8.52% in regular trading, trading at HKD 8.69/share, with trading volume of HKD 142 million.On the news front, the company recently released multiple positive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121378543","title":"PegBio Reports Stable Share Capital in May 2026 and Affirms Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1121378543","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121378543?lang=en_us&edition=fundamental","pubTime":"2026-06-03 17:05","pubTimestamp":1780477526,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. released its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 May 2026, confirming that there were no changes to its share capital structure during...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145158330","title":"PEGBIO CO-B Shares Surge Over 13% in Session as CR059 Accepted for EASD 2026 and Oral Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1145158330","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145158330?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:41","pubTimestamp":1780368088,"startTime":"0","endTime":"0","summary":"Shares of PEGBIO CO-B (02565) experienced a significant intraday surge, climbing more than 13% at one point during the morning session.At the time of writing, the stock was up 4.27%, trading at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","BK1161","BK4588","BK4581","BK4585","02565","161726","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142389682","title":"PEGBIO CO-B Shares Surge Over 13% as CR059 Research Accepted for Presentation at EASD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1142389682","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142389682?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:17","pubTimestamp":1780366627,"startTime":"0","endTime":"0","summary":"Shares of PEGBIO CO-B (HKEX: 02565) have surged more than 13%. At the time of writing, the stock is up 9.8% to HK$8.75, with a turnover of HK$108 million.The significant move follows a company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","BK4581","VXUS","BK4585","BK4588","02565","XBI","BK1161","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185585479","title":"Movement Alert｜PegBio Pharma-B Rises 10.55% in Regular Trading, CR059 EASD Oral Presentation Selection and Buyback Plan Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1185585479","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185585479?lang=en_us&edition=fundamental","pubTime":"2026-06-02 10:05","pubTimestamp":1780365941,"startTime":"0","endTime":"0","summary":"On June 2, PegBio Pharma-B rose 10.55% in regular trading, trading at HK$8.75/share, with trading volume of HK$115 million.On the news front, the company released multiple positive catalysts in quick...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":117,"code":"91000000","status":"200"}]}}